NextGen Genetics joins hands with Luminary Life Sciences to launch genetic testing services

NextGen Genetics, a leading provider of genetic testing services for the reproductive health industry, announced that it is joining Luminary Life Sciences, an expanding suite of life science services that will include precision fertility and prenatal vitamins, donor gamete and surrogacy services, medical devices, and cryogenic storage solutions.NextGen Genetics is one of the fastest growing genetics companies in the United States offering preimplantation genetic testing services. The new entity, which will operate under the name Luminary Genetics, is well-positioned for continued growth and expansion of market services through further investments in research and development and technology that enables continued focus on customer service and genetic counseling.NextGen's leadership in the field is exemplified by their recent introduction of the PGT-A Link test which allows for enhanced testing that can help improve a patient's path to a successful pregnancy. PGT-A Link also confirms the genetic relationship among embryos, providing patients with additional reassurance and confidence regarding their embryos' identity and genetic testing results."I am thrilled to have the opportunity to join forces with Luminary Life Sciences in creating Luminary Genetics. Reproductive genetics has seen significant advances in recent years, and by joining the Luminary Life Sciences family, we can continue to adopt innovative modern technologies to meet these changing, increasing, and diverse needs. Together, we will continue to deliver exceptional outcomes and provide essential and reliable support throughout our clients' family-building journey," said Cengiz Cinnioglu, former founder and CEO of NextGen Genetics, who will continue to lead Luminary Genetics."NextGen Genetics has achieved national recognition in the biotechnology space as a leading provider of advanced genetic testing services for the IVF field. They have an outstanding reputation for laboratory quality, continuous innovation, and customer service," said Carl Zimmerman, Partner, Amulet Capital, an investor in Luminary Life Sciences. "The addition of NextGen Genetics, now Luminary Genetics, to the Luminary Life Science family of brands represents a strategic expansion and an opportunity to drive continued growth. It is thanks to the remarkable work of the entire NextGen Genetics team that the creation of Luminary Genetics became possible. Under Cengiz's leadership, NextGen Genetics has provided a reliable service that patients have come to trust. We will take that same dedication and commitment to new heights under the Luminary Life Sciences banner, to become the preeminent platform that offers the most progressive and sound solutions to serve hopeful parents across the globe."

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!